News for Fortress Biotech (CNB.BE)

Gainers Anchiano Therapeutics (NASDAQ:ANCN) stock moved upwards by 30.53% to $4.36 during Friday's after-market session. At the close, Anchiano ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 2) ...

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.46%

Penny Stocks To Buy According To Analysts Looking for penny stocks to buy right now? You’re obviously not alone. But there’s a bit of a cautious tone in th...

Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...

Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease

Under the terms of the agreement, Sentynl will make $20 million in upfront development and regulatory cash milestones through New Drug Application (NDA) approval in US. Royalties on CUTX-101 net sales ranging from the mid-single digits up to the mid-twenties are also payable.

Sentynl acquires CUTX-101 for $20 mn in upfront and regulatory milestone payments

Fortress Biotech was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020. The information contained in ...

Looking For Penny Stocks to Watch? Check Out These 4 While February has not been the best month for blue-chip stocks, many penny stocks have climbed in the pas...

Analysts Rate These Penny Stocks A Buy Right Now Finding the best penny stocks to buy right now can be a tall order. Not only are you dealing with noise in the...

Posted on Written by Five Disruptive Penny Stocks That You Should Watch The market is blowing up and it’s getting near impossible to find disruptive compani...

LOS ANGELES, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming January 26, 2021 deadline to file a ...

WORCESTER, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang") (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focused on ...

NEW YORK, Jan. 3, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc.?? and certain of its officers.? The class...

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc. ("Fortress" or the "Company") (NASDAQ: FBIO)...

NEW YORK, Jan. 3, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc.  ("Fortress" or the